Incorporating Self-Testing for HIV, Hepatitis, STIs
The emergence of COVID-19 in 2020 and its attendant access challenges prompted more attention to home/se
The emergence of COVID-19 in 2020 and its attendant access challenges prompted more attention to home/se
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource updated 09/19/2023
Blog updated 03/03/2022
Resource from the RWHAP Best Practices Compilation updated on 02/02/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
Resource from the RWHAP Best Practices Compilation updated on 11/26/2023
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource updated 04/07/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023